Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4

Biochemical and Biophysical Research Communications

Volumn 390, Issue 4, 2009, Pages 1121-1125

  Kikuchi, Kiyoshi ^a,b   Tancharoen, Salunya ^c   Matsuda, Fumiyo ^d   Biswas, Kamal Krishna ^a   Ito, Takashi ^a   Morimoto, Yoko ^e   Oyama, Yoko ^a   Takenouchi, Kazunori ^a   Miura, Naoki ^f   Arimura, Noboru ^a   Nawa, Yuko ^a   Meng, Xiaojie ^a   Shrestha, Binita ^a   Arimura, Shinichiro ^a   Iwata, Masahiro ^e   Mera, Kentaro ^e   Sameshima, Hisayo ^a   Ohno, Yoshiko ^a   Maenosono, Ryuichi ^a   Tajima, Yutaka ^b   Uchikado, Hisaaki ^g   Kuramoto, Terukazu ^b   Nakayama, Kenji ^b   Shigemori, Minoru ^g   Yoshida, Yoshihiro ^d   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a   Kawahara, Ko ichi ^a   more..

^a Division of Laboratory and Vascular Medicine   (Japan)

^b Omuta City General Hospital   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aquaporin 4; Cerebral ischemic injury; Edaravone

Indexed keywords

AQUAPORIN 4; NORPHENAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG INHIBITION; IMMUNOREACTIVITY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SCORING SYSTEM;

ANIMALS; ANTIPYRINE; AQUAPORIN 4; BRAIN EDEMA; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FREE RADICAL SCAVENGERS; MALE; RATS;

RATTUS;

EID: 70549090013     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.09.015     Document Type: Article

References (30)

1. Manley G.T., Binder D.K., Papadopoulos M.C., and Verkman A.S. New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice. Neuroscience 129 (2004) 983-991
2. Papadopoulos M.C., Krishna S., and Verkman A.S. Aquaporin water channels and brain edema. Mt. Sinai J. Med. 69 (2002) 242-248
3. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., Chan P., and Verkman A.S. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 6 (2000) 159-163
4. Wang C.X., and Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging 24 (2007) 537-546
5. Green A.R., and Shuaib A. Therapeutic strategies for the treatment of stroke. Drug Discov. Today 11 (2006) 681-693
6. van der Worp H.B., Kappelle L.J., Algra A., Bar P.R., Orgogozo J.M., Ringelstein E.B., Bath P.M., and van Gijn J. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke. Neurology 58 (2002) 133-135
7. Shuaib A., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M., Diener H.C., Ashwood T., Wasiewski W.W., and Emeribe U. NXY-059 for the treatment of acute ischemic stroke. N. Engl. J. Med. 357 (2007) 562-571
8. Watanabe T., Tanaka M., Watanabe K., Takamatsu Y., and Tobe A. Research and development of the free radical scavenger edaravone as a neuroprotectant. Yakugaku Zasshi 124 (2004) 99-111
9. Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc. Dis. 15 (2003) 222-229
10. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225
11. Kikuchi K., Kawahara K.I., Tancharoen S., Matsuda F., Morimoto Y., Ito T., Biswas K.K., Takenouchi K., Miura N., Oyama Y., Nawa Y., Arimura N., Iwata M., Tajima Y., Kuramoto T., Nakayama K., Shigemori M., Yoshida Y., Hashiguchi T., and Maruyama I. The free-radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J. Pharmacol. Exp. Ther. 329 (2009) 865-874
12. Haberg A., Qu H., Saether O., Unsgard G., Haraldseth O., and Sonnewald U. Differences in neurotransmitter synthesis and intermediary metabolism between glutamatergic and GABAergic neurons during 4 hours of middle cerebral artery occlusion in the rat: the role of astrocytes in neuronal survival. J. Cereb. Blood Flow Metab. 21 (2001) 1451-1463
13. Menzies S.A., Hoff J.T., and Betz A.L. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31 (1992) 100-106 (discussion 106-107)
14. Kikuchi K., Kawahara K.I., Biswas K.K., Ito T., Tancharoen S., Morimoto Y., Matsuda F., Oyama Y., Takenouchi K., Miura N., Arimura N., Nawa Y., Jie M.X., Shrestha B., Arimura S., Iwata M., Mera K., Sameshima H., Ohno Y., Maenosono R., Yoshida Y., Tajima Y., Uchikado H., Kuramoto T., Nakayama K., Shigemori M., Hashiguchi T., and Maruyama I. Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem. Biophys. Res. Commun. 385 (2009) 132-136
15. Kawai H., Nakai H., Suga M., Yuki S., Watanabe T., and Saito K.I. Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281 (1997) 921-927
16. Nishi H., Watanabe T., Sakurai H., Yuki S., and Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 20 (1989) 1236-1240
17. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
18. Amemiya S., Kamiya T., Nito C., Inaba T., Kato K., Ueda M., Shimazaki K., and Katayama Y. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur. J. Pharmacol. 516 (2005) 125-130
19. Shichinohe H., Kuroda S., Yasuda H., Ishikawa T., Iwai M., Horiuchi M., and Iwasaki Y. Neuroprotective effects of the free radical scavenger edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 1029 (2004) 200-206
20. Noor J.I., Ikeda T., Mishima K., Aoo N., Ohta S., Egashira N., Iwasaki K., Fujiwara M., and Ikenoue T. Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy. Stroke 36 (2005) 2468-2474
21. Zhu C., Wang X., Huang Z., Qiu L., Xu F., Vahsen N., Nilsson M., Eriksson P.S., Hagberg H., Culmsee C., Plesnila N., Kroemer G., and Blomgren K. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 14 (2007) 775-784
22. Nakamura T., Kuroda Y., Yamashita S., Zhang X., Miyamoto O., Tamiya T., Nagao S., Xi G., Keep R.F., and Itano T. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 39 (2008) 463-469
23. Torii K., Uneyama H., Nishino H., and Kondoh T. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J. Pineal Res. 36 (2004) 18-24
24. Cuzzocrea S., Costantino G., Gitto E., Mazzon E., Fulia F., Serraino I., Cordaro S., Barberi I., De Sarro A., and Caputi A.P. Protective effects of melatonin in ischemic brain injury. J. Pineal Res. 29 (2000) 217-227
25. Kaur C., Sivakumar V., Zhang Y., and Ling E.A. Hypoxia-induced astrocytic reaction and increased vascular permeability in the rat cerebellum. Glia 54 (2006) 826-839
26. Tanimura Y., Hiroaki Y., and Fujiyoshi Y. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J. Struct. Biol. 166 (2009) 16-21
27. Arima H., Yamamoto N., Sobue K., Umenishi F., Tada T., Katsuya H., and Asai K. Hyperosmolar mannitol simulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes. J. Biol. Chem. 278 (2003) 44525-44534
28. Abe S., Kirima K., Tsuchiya K., Okamoto M., Hasegawa T., Houchi H., Yoshizumi M., and Tamaki T. The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical. Chem. Pharm. Bull. (Tokyo) 52 (2004) 186-191
29. Diener H.C., Lees K.R., Lyden P., Grotta J., Davalos A., Davis S.M., Shuaib A., Ashwood T., Wasiewski W., Alderfer V., Hardemark H.G., and Rodichok L. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 39 (2008) 1751-1758
30. Lapchak P.A., and Zivin J.A. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator. Exp. Neurol. 215 (2009) 95-100